Our findings demonstrated that the expression of key enzymes involved in the catabolic metabolism of tyrosine, namely, TAT, HPD, HGD and GSTZ1, was notably reduced in HBV-positive HCC tissues. The gene discussed is HPD; the disease is hepatocellular carcinoma.